First Time Loading...

Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.12 USD -0.22% Market Closed
Updated: Apr 28, 2024

Theravance Biopharma Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theravance Biopharma Inc
Net Income (Common) Peer Comparison

Comparables:

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Theravance Biopharma Inc
NASDAQ:TBPH
Net Income (Common)
-$55.2m
CAGR 3-Years
42%
CAGR 5-Years
24%
CAGR 10-Years
10%

See Also

What is Theravance Biopharma Inc's Net Income (Common)?
Net Income (Common)
-55.2m USD

Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Net Income (Common) amounts to -55.2m USD.

What is Theravance Biopharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%

The average annual Net Income (Common) growth rates for Theravance Biopharma Inc have been 42% over the past three years , 24% over the past five years , and 10% over the past ten years .